Low-, middle-income countries could receive donated H1N1 vaccine shipments by November, WHO says

About 100 low- and middle-income countries could receive donated shipments of the H1N1 (swine flu) vaccine as early as November, Marie-Paule Kieny, of the WHO, told journalists Monday, Agence France-Presse reports. "Dozens of millions of doses are being lined up following offers from pharmaceutical companies," including Sanofi-Aventis, GlaxoSmithKline and MedImmune, as well as a coalition of developed nations "that have pledged to release 10 percent of their vaccine purchases for poor nations," the news service writes (10/12).

"We are trying to have a first delivery starting in November," Kieny said, according to Reuters. "The idea is to start with northern hemisphere countries first." Kieny reemphasized the importance of health workers in these countries being first in line to receive the vaccine "to avoid passing it to the patients they treat and to ensure that hospitals and health clinics can stay open throughout an outbreak," the news service writes. Though H1N1 production yields continue to be lower than those of the seasonal flu vaccine, Kieny said the manufacturers of the H1N1 vaccine have been able to produce more vaccine than originally anticipated (MacInnis, 10/12).

In related news, the Namibian/allAfrica.com examines efforts currently underway in Namibia to ensure the country acquires the H1N1 vaccine from the WHO. "To date, 69 cases of the flu have been confirmed in Namibia, with the number of new cases reported per week having come down slightly in the past few weeks," the news service writes, adding "WHO says vaccine supplies in many low- and middle-income countries - such as Namibia - will 'depend on donations from manufacturers and other countries'" (Shejavali, 10/9).

Meanwhile, on Friday, the WHO announced it could take several years before the organization could downgrade the H1N1 classification "from a pandemic to seasonal-like virus," Reuters reports in a separate story. "Eventually a pandemic virus becomes more like a seasonal virus and that normally will take something like two to three years," WHO spokesperson Gregory Hartl said. "Once enough people either have been vaccinated or have contracted the virus, then it becomes more difficult to spread. It starts acting like a seasonal flu." Hartl warned there was no sign the virus had started to slow down (MacInnis, 10/9).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO grants Emergency Use Listing for LC16m8 mpox vaccine